View allAll Photos Tagged stemcells
Rob T. A. Janssen, Secretary-General, Alliance for Advanced Therapies
What is the state of R&D, funding, and infrastructure in Europe? This Science|Business Policy Roundtable took place at the UK Representation to the EU in Brussels on 18 October 2012.
Regenerative Medicine is one of the most exciting and promising fields of biomedical research today. Europe currently leads the world in therapeutic applications and medicines in this technology, and has successfully seen the first companies working in the field to spin-out from research universities with EMA approved products currently in the market.
However, with the recent patent ruling by the European Court of Justice and the debate regarding continued funding in Horizon 2020, what challenges exist for Europe to maintain its research lead in this field?
Science|Business hosted a roundtable discussion of thought leaders and policy to make recommendations as to what the EU should do to improve the infrastructure and research climate for new stem cell technologies and regenerative medicines in Europe.
Pictures by Carlos Nomen
The University of Louisville Division of Cardiovascular Medicine presented the 21st Annual Leonard Leight Lecture on December 10, 2014 in Kornhauser Auditorium on the UofL Health Sciences campus.
The special guest speaker for 2014 was Victor J. Dzau, M.D., President of the Institute of Medicine.
Dr. Dzau presented "Molecular Approaches to Cardiac Regeneration" focusing on understanding cell-based therapy for cardiac regeneration.
Suchitra Sumitran-Holgersson, Professor of Transplantation Biology, University of Gothenburg
Arnd Hoeveler, Head of Unit, Advanced Therapies and Systems Medicine, DG Research & Innovation, European Commission
What is the state of R&D, funding, and infrastructure in Europe? This Science|Business Policy Roundtable took place at the UK Representation to the EU in Brussels on 18 October 2012.
Regenerative Medicine is one of the most exciting and promising fields of biomedical research today. Europe currently leads the world in therapeutic applications and medicines in this technology, and has successfully seen the first companies working in the field to spin-out from research universities with EMA approved products currently in the market.
However, with the recent patent ruling by the European Court of Justice and the debate regarding continued funding in Horizon 2020, what challenges exist for Europe to maintain its research lead in this field?
Science|Business hosted a roundtable discussion of thought leaders and policy to make recommendations as to what the EU should do to improve the infrastructure and research climate for new stem cell technologies and regenerative medicines in Europe.
Pictures by Carlos Nomen
This image shows a young worm on top, which is capable of maintaining the model disease protein in a benign, soluble state. The older worm, below, can no longer maintain protein solubility and displays the accumulation of toxic, polyglutamine aggregates.
The University of Louisville Division of Cardiovascular Medicine presented the 21st Annual Leonard Leight Lecture on December 10, 2014 in Kornhauser Auditorium on the UofL Health Sciences campus.
The special guest speaker for 2014 was Victor J. Dzau, M.D., President of the Institute of Medicine.
Dr. Dzau presented "Molecular Approaches to Cardiac Regeneration" focusing on understanding cell-based therapy for cardiac regeneration.
Roberto Bolli, M.D., FAHA, FACC, chief of the University of Louisville Division of Cardiovascular Medicine and director of UofL's Institute of Molecular Cardiology in the Department of Medicine and his team receive a $13.8 million award from the National Institutes of Health to study a promising new type of adult cardiac stem cell that has the potential to treat heart failure. The NIH grant is a continuation of a Program Project Grant (PPG) that Bolli and his team were originally awarded in 2005.
Roberto Bolli, M.D., FAHA, FACC, chief of the University of Louisville Division of Cardiovascular Medicine and director of UofL's Institute of Molecular Cardiology in the Department of Medicine and his team receive a $13.8 million award from the National Institutes of Health to study a promising new type of adult cardiac stem cell that has the potential to treat heart failure. The NIH grant is a continuation of a Program Project Grant (PPG) that Bolli and his team were originally awarded in 2005.
The University of Louisville Division of Cardiovascular Medicine presented the 21st Annual Leonard Leight Lecture on December 10, 2014 in Kornhauser Auditorium on the UofL Health Sciences campus.
The special guest speaker for 2014 was Victor J. Dzau, M.D., President of the Institute of Medicine.
Dr. Dzau presented "Molecular Approaches to Cardiac Regeneration" focusing on understanding cell-based therapy for cardiac regeneration.
Gil Beyen, Managing Director and Chief Business Officer, TiGenix
What is the state of R&D, funding, and infrastructure in Europe? This Science|Business Policy Roundtable took place at the UK Representation to the EU in Brussels on 18 October 2012.
Regenerative Medicine is one of the most exciting and promising fields of biomedical research today. Europe currently leads the world in therapeutic applications and medicines in this technology, and has successfully seen the first companies working in the field to spin-out from research universities with EMA approved products currently in the market.
However, with the recent patent ruling by the European Court of Justice and the debate regarding continued funding in Horizon 2020, what challenges exist for Europe to maintain its research lead in this field?
Science|Business hosted a roundtable discussion of thought leaders and policy to make recommendations as to what the EU should do to improve the infrastructure and research climate for new stem cell technologies and regenerative medicines in Europe.
Pictures by Carlos Nomen
Scientists at the University of Cambridge have managed to create a structure resembling a mouse embryo in culture, using two types of stem cells — the body’s ‘master cells’ — and a 3D scaffold on which they can grow.
Understanding the very early stages of embryo...
www.bioadvisers.com/scientists-create-artificial-mouse-em...
Erik Tambuyzer, Managing Director, Center for Biomedical Innovation (CMI)
What is the state of R&D, funding, and infrastructure in Europe? This Science|Business Policy Roundtable took place at the UK Representation to the EU in Brussels on 18 October 2012.
Regenerative Medicine is one of the most exciting and promising fields of biomedical research today. Europe currently leads the world in therapeutic applications and medicines in this technology, and has successfully seen the first companies working in the field to spin-out from research universities with EMA approved products currently in the market.
However, with the recent patent ruling by the European Court of Justice and the debate regarding continued funding in Horizon 2020, what challenges exist for Europe to maintain its research lead in this field?
Science|Business hosted a roundtable discussion of thought leaders and policy to make recommendations as to what the EU should do to improve the infrastructure and research climate for new stem cell technologies and regenerative medicines in Europe.
Pictures by Carlos Nomen
Jual Obat Autoimun Psoriasis Herbal ke Makassar, SOP 100 Lupus, SOP 100+ odapus , SOP 100 insomnia + , SOP 100+ odapus, SOP 100 vitiligo+ , Sop 100+minumansehat ,
,sopsubarashi, Sop 100autoimun , Sop 100 fullmoon, Sop 100+ flare, Testimoni Sop 100 bluemoon, Sop 100+ Salmon Ovary Peptide minumansehat
APA ITU PENYAKIT AUTOIMMUN?
Penyakit Auto Imun Adalah Suatu penyakit ketika sistem kekebalan tubuh menyerang sel-sel sehat. Bahayanya, penyakit autoimun ini bisa mengakibatkan kerusakan sel jaringan dalam tubuh dan menimbulkan peradangan serta mengakibatkan kondisi yang serius pada penderitanya, seperti gangguan pada tulang persendian, saraf, kelenjar, dan organ-organ penting lainnya
Hampir setiap provinsi di Indonesia warnya ada yang mengidap penyakit Autoimun, Salmon Ovary Peptide SOP100+ dan SOP Subarashi banyak dikirim untuk membantu pengobatan ke setiap daerah
Salmon Ovary Peptide Siap dikirim ke Setiap Kabupaten :
1). Kabupaten Bandung
2). Kabupaten Bandung Barat
3). Kabupaten Bekasi
4). Kabupaten Bogor
5). Kabupaten Ciamis
6). Kabupaten Cianjur
7). Kabupaten Cirebon
8). Kabupaten Garut
9). Kabupaten Indramayu
10). Kabupaten Karawang
11). Kabupaten Kuningan
12). Kabupaten Majalengka
13). Kabupaten Pangandaran
14). Kabupaten Purwakarta
15). Kabupaten Subang
16). Kabupaten Sukabumi
17). Kabupaten Sumedang
18). Kabupaten Tasikmalaya
19). Kota Bandung
20). Kota Banjar
21). Kota Bekasi
22). Kota Bogor
23). Kota Cimahi
24). Kota Cirebon
25). Kota Depok
26). Kota Sukabumi
27). Kota Tasikmalaya
Jenis Penyakit Autoimun
Yang paling banyak dari 80jenis yang dikategorikan jenis penyakit autoimun adalah sebagai berikut :
Artritis reumatoid
Artritis reumatoid Cenderung penyakit ini menggantu kesehatan anda dalam persendian disebut dengan gangguan inflamasi kronis. Jadi yang anda rasakan bisa nyeri sendi, Sendi bengkak, Sendi kemerahan, terasa hangat. Dua jenis arthritis yang paling umum ditemui adalah osteoarthritis (OA) dan rheumatoid arthritis (RA).
Lupus Eritematosus Sistemik
Ini sering disebut penyakit mematikan dalam kategorinya. Penyakit radang yang disebabkan ketika sistem kekebalan tubuh menyerang jaringannya sendiri. Pada gangguan penyakit ini, serangan lupus ini dapat memengaruhi organ-organ seperti seperti ginjal, kulit, sistem muskoskleletal, sistem kardiovaskular, sistem saraf pusat dan tepi, dan darah. Umur 15-45 cenderung di serang penyakit ini
Penyakit seliak
Penyakit ini terjadi pada orang yang sering bermasalah dengan diare dalam jangka panjang mempengaruhi usus kecil. Reaksi kekebalan terhadap konsumsi gluten, yaitu protein yang terkandung dalam gandum, jelai, dan gandum hitam.
Sindrom Sjรถgren
Penyakit ini cenderung di dominasi oleh wanita di atas umur 40tahun. Gangguan sistem kekebalan tubuh yang ditandai dengan mata kering dan mulut kering. Karena langsung mengganggu kelenjar penghasil cairan seperti kelenjar air liur dan air mata. Untuk mata ini ada yang merasa mata kering, rasa terbakar dan juga gatal.
Polimialgia Reumatika
Bermasalah pada bahu, leher, dan panggul, eits jangan-jangan gangguan inflamasi yang menyebabkan nyeri otot dan kekakuan di bahu dan pinggul, ini masuk kategori autoimun ini. Cenderung di derita oleh usia lanjut dan memang banyak terjadi karena peradangan dan infeksi.
Sklerosis multipel
Kalau anda sudah diperiksa dokter dan vonisnya berasalah dengan pelindung saraf, maka Suatu penyakit saat sistem kekebalan tubuh menggerogoti lapisan pelindung saraf (sklerosis multipel). sistem kekebalan tubuh mengeluarkan reaksi abnormal dan menyerang sistem saraf pusat, terutama otak.
Spondilitis ankilosa
Masih berhubungan dengan sendi-sendi besar. Peradangan kronis yang dapat menyebabkan menutupnya celah antar ruas tulang belakang, terjadinya penyakit bungkuk. Selain menyerang tulang belakang bisa juga bagian sendi tubuh lainnya, jika terus penyakitnya berlanjut.
Diabetes Tipe 1
Sudah sering kita dengar penyakit ini, tapi ada 2 jenis tipe 1 dan tipe 2. Tipe 1 termasuk suatu kondisi kronis saat pankreas memproduksi insulin sedikit atau tidak sama sekali. Ini bisa terjadi sejak usia dari anak-anak. Jadi prosesnya memang jangka panjang ya.
Alopesia Areata
Mungkin jarang terjadi dimana kebotakan terjadi hanya daerah terentu, apakah itu di atas kepala, disamping atau di belakang membentuk lingkaran, bisa juga tumpang tindih. Selain hanya kebotakan juga bisa terjadi gangguan emosional yang dapat menyebabkan gangguan kecemasan dan depresi
Arteritis temporalis
Penyakit yang terjadi sekitar kepala. Peradangan pembuluh darah, yang disebut arteri, di dalam dan di sekitar kulit kepala. Gejala berupa sakit kepala, nyeri rahang, gangguan penglihatan, demam, dan kelelahan. Diagnosis biasanya membutuhkan biopsi arteri temporal.
Radang pembuluh darah
Penyakit Peradangan pembuluh darah dalam medis disebut dengan vaskulitis yang menyebabkan perubahan dalam dinding pembuluh darah. Komplikasi vaskulitis meliputi: Kerusakan organ: Beberapa jenis vaskulitis parah bisa menyebabkan kerusakan pada organ utama. Gumpalan darah dan aneurisma: Gumpalan darah dapat terbentuk di pembuluh darah, menghalangi aliran darah.
Penyakit inilah yang di derita oleh anak ibu yang kita ceritakan paling awal tadi.
Obat Autoimun Alami
Sebenarnya pertanyaan yang paling banyak adalah, apakah penyakit autoimun ini bisa sembuh total? Menurut para medis bahwa penyakit ini mirip seperti penyakit diabetes atau hipertensi. Tidak bisa sembuh total tetapi pengidap penyakit tersebut bisa dikontrol kesehatannya dan tetap hidup seperti biasa.
Tentu berbahaya kalau dalam jangka waktu lama tidak ditangani dengan baik, karena itu perlu di kontrol dan di konsultasikan dengan dokter. Seiring dengan berjalannya waktu bisa dibantu dengan obat herbal untuk radang pembuluh darah yang disebut dengan medis Vaskulitis.
Salmon Ovary Peptide
Penyakit autoimun adalah kondisi ketika sistem kekebalan tubuh seseorang menyerang tubuhnya sendiri. Pada seseorang yang menderita penyakit autoimun, sistem kekebalan tubuhnya melihat sel tubuh yang sehat sebagai asing.
Salmon Ovary Peptide membantu tubuh untuk meregenerasi kembali sel-sel dalam tubuh yang sudah dirusak oleh imun itu sendiri. Salmon Ovary Peptide terbuat dari ikan Oncorhynchus Keta Salmon yang memiliki kandungan bahan aktif yang lebih tinggi dari plasenta manusia ataupun plasenta mamalia. Telah diteliti oleh para ahli di AFC Life Science yang berkolaborasi dengan ilmuwan terkemuka.
Sudah diakui oleh pemerintah Jepang dengan 3paten, salah satunya adalah Patent JP 3946238: Anti-Aging/Cell Regeneration Effect, untuk meregenerasi sel dan mengaktifkan kembali stemcell yang rusak di dalam tubuh. Semoga Manfaat Salmon Ovary Peptide semakin banyak dirasakan oleh para penderita autoimmun ini.
Cara Pemakaian / Minum SOP 100+ atau SOP Subarashi :
Taruh serbuk di bawah lidah paling bagus dikonsumsi pagi hari antara jam 5 sd jam 9 pagi setelah bangun tidur sebelum makan apapun.
Untuk menjaga kesehatan bisa konsumsi 1x1 per hari. Untuk penyembuhan sakit bisa di tambahkan dosis sampai 4x1 per hari, tergantung kondisi penyakit.
Beli SOP 100+ atau SOP Subarashi
Mr. Eric, Hp. 0857 6780 7007
Whatsapp : 0878 9381 1922 atau
Klik Watsapp Otomatis
Web : www.SalmonHomeComing.com
Map : g.page/agenresmisop100plus
FB : PengobatanRegenerasiSel
The University of Louisville Division of Cardiovascular Medicine presented the 21st Annual Leonard Leight Lecture on December 10, 2014 in Kornhauser Auditorium on the UofL Health Sciences campus.
The special guest speaker for 2014 was Victor J. Dzau, M.D., President of the Institute of Medicine.
Dr. Dzau presented "Molecular Approaches to Cardiac Regeneration" focusing on understanding cell-based therapy for cardiac regeneration.
The University of Louisville Division of Cardiovascular Medicine presented the 21st Annual Leonard Leight Lecture on December 10, 2014 in Kornhauser Auditorium on the UofL Health Sciences campus.
The special guest speaker for 2014 was Victor J. Dzau, M.D., President of the Institute of Medicine.
Dr. Dzau presented "Molecular Approaches to Cardiac Regeneration" focusing on understanding cell-based therapy for cardiac regeneration.
UCSD assistant bioengineering professor Karen Christman is developing a novel and innovative multi-layer patterning technique that will provide step-by-step cues for cell and tissue development.
Caricord is a FDA licensed stem cell bank at the University of Colorado and this video explains why expectant parents should consider banking their newborn’s umbilical cord blood and tissue. Watch the video to learn the benefits of family cord blood banking.
Thomas Dentzer, Luxembourg BioHealth Cluster Manager, Luxinnovation
What is the state of R&D, funding, and infrastructure in Europe? This Science|Business Policy Roundtable took place at the UK Representation to the EU in Brussels on 18 October 2012.
Regenerative Medicine is one of the most exciting and promising fields of biomedical research today. Europe currently leads the world in therapeutic applications and medicines in this technology, and has successfully seen the first companies working in the field to spin-out from research universities with EMA approved products currently in the market.
However, with the recent patent ruling by the European Court of Justice and the debate regarding continued funding in Horizon 2020, what challenges exist for Europe to maintain its research lead in this field?
Science|Business hosted a roundtable discussion of thought leaders and policy to make recommendations as to what the EU should do to improve the infrastructure and research climate for new stem cell technologies and regenerative medicines in Europe.
Pictures by Carlos Nomen
Richard L. Hudson, CEO & Editor, Science|Business
What is the state of R&D, funding, and infrastructure in Europe? This Science|Business Policy Roundtable took place at the UK Representation to the EU in Brussels on 18 October 2012.
Regenerative Medicine is one of the most exciting and promising fields of biomedical research today. Europe currently leads the world in therapeutic applications and medicines in this technology, and has successfully seen the first companies working in the field to spin-out from research universities with EMA approved products currently in the market.
However, with the recent patent ruling by the European Court of Justice and the debate regarding continued funding in Horizon 2020, what challenges exist for Europe to maintain its research lead in this field?
Science|Business hosted a roundtable discussion of thought leaders and policy to make recommendations as to what the EU should do to improve the infrastructure and research climate for new stem cell technologies and regenerative medicines in Europe.
Pictures by Carlos Nomen
The University of Louisville Division of Cardiovascular Medicine presented the 21st Annual Leonard Leight Lecture on December 10, 2014 in Kornhauser Auditorium on the UofL Health Sciences campus.
The special guest speaker for 2014 was Victor J. Dzau, M.D., President of the Institute of Medicine.
Dr. Dzau presented "Molecular Approaches to Cardiac Regeneration" focusing on understanding cell-based therapy for cardiac regeneration.